advisorsecurities master

TLSATiziana Life Sciences Ltd. Common Shares

CSNasdaq (XNAS)·USD

Identity

Security key
22569
Ticker
TLSA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2018-11-20
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
TLSA

Detail

Enriched 2026-08-14 20:47

Market cap
$125,986,539.69
Shares outstanding (class)
120,507,401
Shares outstanding (weighted)
127,259,131
SIC
Employees
10
Location
Description

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data